XWELL (NASDAQ:XWEL – Get Rating) and CVS Group (OTCMKTS:CVSGF – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership. Insider and Institutional Ownership 10.9% of XWELL shares are owned by […]
XWELL (NASDAQ:XWEL – Get Rating) had its price target cut by HC Wainwright from $1.50 to $1.00 in a research report report published on Tuesday, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for XWELL’s Q1 2023 earnings at ($0.07) EPS, Q2 2023 earnings at ($0.03) […]
XWELL, Inc. (NASDAQ:XWEL – Get Rating) – Equities research analysts at HC Wainwright raised their Q1 2023 EPS estimates for shares of XWELL in a report released on Tuesday, April 4th. HC Wainwright analyst S. Buck now expects that the company will post earnings per share of ($0.07) for the quarter, up from their prior […]